Trial Profile
Clinical Trials Insight: 700012672
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 16 Mar 2006
Price :
$35
*
At a glance
- Drugs Gabapentin enacarbil (Primary)
- Indications Restless legs syndrome
- Focus Adverse reactions; Registrational
- Sponsors XenoPort
- 16 Mar 2006 New trial record.